Sanofi
Method for predicting the outcome of a treatment with aflibercept of a patient suspected to suffer from a cancer
Last updated:
Abstract:
The present invention concerns the use of interleukin-8 (IL-8) as a biomarker for predicting the outcome of the treatment with aflibercept, or ziv-aflibercept of a patient suspected to suffer from a cancer.
Status:
Grant
Type:
Utility
Filling date:
24 Oct 2019
Issue date:
28 Dec 2021